1.Isolation and Drug Resistance Situations of Escherichia coli from Urine Specimens in 2002-2007
Jinchuan ZHENG ; Xiaotao ZHENG ; Guoqiang CHEN
Chinese Journal of Nosocomiology 2009;0(23):-
50.0%).ESBLs isolates reached up 63.5%.CONCLUSIONS E.coli has a high detection rate and serious drug resistance in urinary infections.Conventional ESBLs tests can help to appropriate use antibiotics and lower the occurrence of drug resistance.Clinical doctors are advised to restrict the usage of antibiotics in order to lower the occurrence of drug resistance strains,as well as to prevent the spread of ESBLs.
2.Hospital-acquired Infection in General ICU: Analysis of Pathogen Distribution and Related Factors
Chuan ZHANG ; Hui XIE ; Lidong JIANG ; Jinchuan CHENG ; Bixia ZHENG ; Qi WEI ; Xiaojin LI
Chinese Journal of Nosocomiology 2006;0(02):-
OBJECTIVE To investigate the distribution of bacteria in general ICU then discuss the susceptible factors and the treatment.METHODS A retrospective analysis of clinical information was performed on 123 patients diagnosed infection who stayed in ICU from May 2002 to May 2004.RESULTS Most of bacteria resulted in infection of general ICU were Gram-negative(62.88%) and then Gram-positive(19.65%). Fungal infection accounted for 17.47%.Pseudomonas aeruginosa occupied the highest percentage among Gram-negative bacteria.Most of Gram-positive bacteria were Staphylococcus aureus and all of them were MRS.The infection site in ICU focused on lower respiratory tract(89.09%).The second was urinary tract(11.79%).CONCLUSIONS Most of the bacteria causing infection in general ICU locate in respiratory tract.They are mainly Gram-negative.All of the Gram-positive bacteria are MRS.The risk factors of hospital-acquired infection are related with patient′s age,underlying disease,intensive care time,ventilation time and invasive operation.
3.Hospital-acquired Gram-positive Infection in General ICU
Chuan ZHANG ; Bixia ZHENG ; Hui XIE ; Lidong JIANG ; Jinchuan CHENG ; Qi WEI ; Xiaoyu LI
Chinese Journal of Nosocomiology 2006;0(07):-
OBJECTIVE To investigate the characteristic of Gram-positive bacteria in general ICU then discuss the susceptible factors and the treatment.METHODS A retrospective analysis of clinical information was performed on patients with Gram-positive infection in ICU from May 2002 to May 2004.RESULTS Most of Gram-positive bacteria resulted in infection in general ICU were Staphylococcus aureus and all of them were MRSA.The infective site focused on lower respiratory tract(84.44%).The second was catheter(8.89%).CONCLUSIONS The risk factors of hospital-acquired infection are relative with patient's age,underlying diseases,stay time in ICU,ventilated time and invasive operation.
4.Clinical implications of increased expression of CD40L in patients with acute coronary syndromes.
Jinchuan YAN ; Zonggui WU ; Zuo HUANG ; Li LI ; Renqian ZHONG ; Xiantao KONG
Chinese Medical Journal 2002;115(4):491-493
OBJECTIVETo investigate clinical implications of expression of CD40L in monocytes and changes in serum soluble CD40L in patients with acute coronary syndromes (ACS).
METHODSSixteen control and 56 patients, including 24 with stable angina (SA), 20 with unstable angina (UA) and 12 with acute myocardial infarction (AMI) enrolled in this study. Expression of CD40L in monocytes was analyzed by flow cytometry and sCD40L levels were measured by ELISA.
RESULTSExpression of CD40L in monocytes and serum levels of sCD40L in UA and AMI patients were higher than in SA patients and controls. In patients with AMI, sCD40L levels showed no significant increase when compared to patients with UA, while AMI patients had a peak level of sCD40L at 24 hours after AMI. PTCA induced a marked rise in sCD40L levels in all patients, while CD40L expression in monocytes showed no difference between patients with PTCA, before and after.
CONCLUSIONEnhanced level of serum sCD40L may be a reliable prognostic indicator for ACS and may represent a marker of coronary disease activity.
Angina Pectoris ; blood ; pathology ; CD40 Ligand ; blood ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Male ; Monocytes ; metabolism ; Myocardial Infarction ; blood ; pathology
5.Dynamic Changes in DNA Damage and Repair Biomarkers with Employment Length among Nickel Smelting Workers.
Shan WU ; Ya Na BAI ; Hong Quan PU ; Jie HE ; Tong Zhang ZHENG ; Hai Yan LI ; Min DAI ; Ning CHENG
Biomedical and Environmental Sciences 2015;28(9):679-682
Our study explored the dynamic changes in and the relationship between the DNA damage marker 8-hydroxy-2'-deoxyguanosine (8-OHdG) and the DNA repair marker 8-hydroxyguanine DNA glycosidase 1 (hOGG1) according to the length of occupational employment in nickel smelting workers. One hundred forty nickel-exposed smelting workers and 140 age-matched unexposed office workers were selected from the Jinchang cohort. The 8-OHdG levels in smelting workers was significantly higher than in office workers (Z=-8.688, P<0.05) and the 8-OHdG levels among nickel smelting workers in the 10-14 y employment length category was significantly higher than among all peers. The hOGG1 levels among smelting workers were significantly lower than those of non-exposed workers (Z=-8.948, P<0.05). There were significant differences between employment length and hOGG1 levels, with subjects employed in nickel smelting for 10-14 y showing the highest levels of hOGG1. Correlation analysis showed positive correlations between 8-OHdG and hOGG1 levels (r=0.413; P<0.01). DNA damage was increased with employment length among nickel smelting workers and was related to the inhibition of hOGG1 repair capacity.
Biomarkers
;
Case-Control Studies
;
Cohort Studies
;
DNA Damage
;
drug effects
;
DNA Glycosylases
;
blood
;
DNA Repair
;
Deoxyadenosines
;
blood
;
Humans
;
Male
;
Metallurgy
;
Nickel
;
toxicity
;
urine
;
Occupational Exposure
;
adverse effects
;
Time Factors
6.Next generation sequencing analysis of drug metabolism related IncRNA in children after living donor liver transplantation
Tian QIN ; Xiangqian GU ; Jianxin ZHENG ; Jinchuan LIU ; Yuanjia TANG ; Feng XUE ; Qiang XIA
Chinese Journal of Organ Transplantation 2019;40(4):219-225
Objective To employ high-throughput next generation sequencing (NGS) for analyzing the expression of lneRNAs and mRNAs in donor samples from pediatric living donor liver transplantation and search differentially expressed lncRNAs and drag metabolic gene for individualized guidance of immunosuppressive agents.Methods Between October 2016 and December 2017,10 liver tissue specimens from living donor liver transplantation children were collected and divided into fast and slow metabolic groups (n =5 each) according to the postoperative profiles of drug metabolism.Samples were assayed for high-throughput NGS.Target analysis was used for functional pathways and screening target genes prediction.Results There were differentially expressed 908 mRNAs and 1228 lncRNAs between slow metabolic and fast metabolic groups (P<0.05).According to the abundance and difference,22 up-regulated and 18 down-regulated mRNAs,13 up-regulated and 24 down-regulated lncRNAs were selected.In addition to CYP3A5,CYP2C19,CYP1A2 and UGT1A1 might affect the metabolism of tacrolimus.At the same time,NONHSAT108617.2 in differemially expressed lncRNAs might regulate the expression of CYP3A5 gene.Conclusions This study has comprehensively analyzed the expression of lncRNAs in donor liver from pediatric liver transplantation.Some differentially expressed drug metabolism related genes may affect tacrolimus metabolism in vivo and thus the postoperative use of immunosuppressive drugs.
7.Trend Analysis of Cancer Mortality in the Jinchang Cohort, China, 2001-2010.
Hong Mei QU ; Ya Na BAI ; Ning CHENG ; Min DAI ; Tong Zhang ZHENG ; Dennis WANG ; Hai Yan LI ; Xiao Bin HU ; Juan Sheng LI ; Xiao Wei REN ; Hui SHANG
Biomedical and Environmental Sciences 2015;28(5):364-369
OBJECTIVETo describe the baseline data of cancers in the Jinchang Cohort, this paper examined trends in cancer mortality among adults investigated in Jinchang, Gansu province from 2001 to 2010.
METHODSMortality data were collected from company departments through administrative documents, death certificates, etc. Trend analyses of cancer mortality were performed on the basis of 925 cancer deaths between 2001 and 2010.
RESULTSThe crude mortality rate of cancer continuously increased from 161.86 per 100,000 in 2001 to 315.32 per 100,000 in 2010, with an average increase of 7.69% per year in the Jinchang Cohort (16.41% in females compared to 6.04% in males), but the age-standardized mortality rate increased only in females. Thirteen leading cancers accounted for 92.10% of all cancer deaths. The five leading causes of cancer mortality in males were lung, gastric, liver, esophageal, and colorectal cancer, whereas those in females were lung, liver, gastric, breast, and esophageal cancer.
CONCLUSIONThe overall cancer mortality rate increased from 2001 to 2010 in the Jinchang Cohort, with greater rate of increase in females than in males. Lung, breast, and gastric cancer, in that order, were the leading causes of increased cancer mortality in females.
Adult ; China ; epidemiology ; Cohort Studies ; Female ; Humans ; Male ; Neoplasms ; epidemiology ; mortality ; Retrospective Studies ; Time Factors
8.Association between fatty liver and type 2 diabetes in the baseline population of Jinchang Cohort.
Y B MA ; N CHENG ; Y B LU ; H Y LI ; J S LI ; J DING ; S ZHENG ; Y L NIU ; H Q PU ; X P SHEN ; H D MU ; X B HU ; D S ZHANG ; Y N BAI
Chinese Journal of Epidemiology 2018;39(6):760-764
Objective: To explore the association between fatty liver and type 2 diabetes mellitus (T2DM) in the baseline-population of Jinchang cohort study. Methods: Data from all the participants involved in the baseline-population of Jinchang cohort study was used, to compare the risks of T2DM in fatty liver and non fatty liver groups and to explore the interaction between family history or fatty liver of diabetes and the prevalence of T2DM. Results: Among all the 46 861 participants, 10 574 were diagnosed as having fatty liver (22.56%), with the standardized rate as 20.66%. Another 3 818 participants were diagnosed as having T2DM (8.15%) with standardized rate as 6.90%. The prevalence of T2DM increased in parallel with the increase of age (trend χ(2)=2 833.671, trend P<0.001). The prevalence of T2DM in the fatty liver group was significantly higher than that in the non-fatty liver group, both in men or women and in the overall population. Compared with the group of non-fatty liver, the risks of T2DM in fatty liver group were seen 1.78 times higher in males, 2.33 times in women and 2.10 times in the overall population, after adjustment for factors as age, levels of education, smoking, drinking, physical exercise, BMI, family history of diabetes and some metabolic indicators (pressure, TC, TG, uric acid, ALT, AST, gamma-glutamyl transferase). Date from the interaction model showed that fatty liver and family history of diabetes present a positive additive interaction on T2DM (RERI=1.18, 95%CI: 0.59-1.78; AP=0.24, 95%CI: 0.14-0.34; S=1.43, 95%CI: 1.21-1.69). Conclusions: Fatty liver could significantly increase the risk of T2DM and a positive additive interaction was also observed between fatty liver and family history of diabetes on T2DM. It was important to strengthen the prevention program on T2DM, in order to effectively control the development of fatty liver.
China/epidemiology*
;
Cohort Studies
;
Diabetes Mellitus, Type 2/ethnology*
;
Fatty Liver/ethnology*
;
Female
;
Humans
;
Male
;
Non-alcoholic Fatty Liver Disease/epidemiology*
;
Prevalence
;
Risk Factors
9.Disease burden of liver cancer in Jinchang cohort.
Xiaobin HU ; Yana BAI ; Hongquan PU ; Kai ZHANG ; Ning CHENG ; Haiyan LI ; Xiping SHEN ; Fuxiu LI ; Xiaowei REN ; Jinbing ZHU ; Shan ZHENG ; Minzhen WANG ; Min DAI
Chinese Journal of Epidemiology 2016;37(3):321-324
OBJECTIVETo understand the current status of the disease burden of liver cancer in Jinchang cohort.
METHODSAll the liver cancer death data from 2001 to 2013 and medical records of liver cancer cases from 2001 to 2010 in Jinchang cohort were collected for the analyses of the mortality, standardized mortality, potential years of life lost (PYLL) and working PYLL (WPYLL) associated with liver cancer. Spearman correlation and the average growth rate were used to analyze the trends.
RESULTSA total of 207 liver cancer deaths occurred in Jinchang cohort from 2001 to 2013, accounting for 16.68% of total cancer deaths. There were 259 liver cancer inpatients, accounting for 6.79% of the total cancer cases inpatients, in which 83 died (32.05%). Liver cancer death mainly occurred in males, accounting for 88.89%, and the liver cancer deaths in females accounted for 11.11%. The standardized mortality rate was 42.32/100,000 in males and 15.31/100,000 in females. The growth rate of liver cancer mortality was 5.62% from 2001 to 2013. Liver cancer deaths mainly occurred in age groups 60-69 years (26.57%) and 50-59 years (24.15%). The PYLL was 2906.76 person-years, the average PYLL was 14.04 years. The WPYLL was 1477.00 person-years and the average WPYLL was 7.14 years. The direct economic burden of liver cancer was 6270.78 Yuan per person, 301.75 Yuan per day. The average stay of hospitalization was 21.32 days.
CONCLUSIONThe mortality rate of liver cancer is increasing and the disease burden is still heavy.
Aged ; China ; epidemiology ; Cohort Studies ; Cost of Illness ; Female ; Hospitalization ; economics ; statistics & numerical data ; Humans ; Liver Neoplasms ; economics ; mortality ; Male ; Middle Aged
10.Disease burden of lung cancer in Jinchang cohort.
Shan ZHENG ; Hongquan PU ; Min DAI ; Yana BAI ; Haiyan LI ; Sheng CHANG ; Minzhen WANG ; Zhengfang WANG ; Jinbing ZHU ; Xiaowei REN ; Juansheng LI ; Ning CHENG
Chinese Journal of Epidemiology 2016;37(3):311-315
OBJECTIVETo understand the current status of lung cancer disease burden in Jinchang cohort.
METHODSIn this historical cohort study, the mortality data of the lung cancer from 2001 to 2013 and medical records of the lung cancer cases from 2001 to 2010 in Jinchang cohort were used, analyze mortality, direct economic burden, potential years of life lost (PYLL) and working PYLL (WPYLL) associated with lung cancer.
RESULTSA total of 434 lung cancer deaths occurred in Jinchang cohort from 2001 to 2013. The crude mortality rate of lung cancer was 78.06 per 100,000 from 2001 to 2013, with the increasing rate of 4.77%. The mortality rate of lung cancer in males and females were about 108.90 per 100,000 and 26.08 per 100,000 with the increasing rate of 4.24% and 6.91%, respectively. During the thirteen years, the PYLL and average PYLL (APYLL) of lung cancer were 3 721.71 person-years and 8.58 years. The APYLL of lung cancer in females (15.94 years) was higher than that in males (7.87 years). The WPYLL and the average WPYLL (AWPYLL) of lung cancer were 1161.00 person-years and 2.68 years, respectively. The AWPYLL of lung cancer was also higher in females than in males. The direct economic burden of lung cancer from 2001 to 2010 in Jinchang cohort was 6309.39 Yuan per case with no increased trend.
CONCLUSIONLung cancer is the main health problem in Jinchang cohort, causing heavy disease burden.
China ; epidemiology ; Cohort Studies ; Cost of Illness ; Female ; Humans ; Lung Neoplasms ; economics ; mortality ; Male